Mode
Text Size
Log in / Sign up

HSV-Net achieves higher Dice scores for pulmonary nodule segmentation than nnU-Net v2New AI Model Shows Better Accuracy for Lung Cancer Imaging

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that HSV-Net provides higher Dice scores for pulmonary nodule segmentation than nnU-Net v2.

This technical report and methodology validation evaluates the performance of the HSV-Net (Hybrid State-space-Vision Network) for the segmentation of pulmonary nodules on chest CT scans. The study compares HSV-Net against the nnU-Net v2 standard to assess accuracy and processing speed.

In the QIN dataset (n=12 tumors), HSV-Net achieved a Dice score of 90.1% (95% CI [88.9, 91.3]), which was higher than the 88.6% reported for nnU-Net v2. In the larger LIDC-IDRI dataset (n=294 nodules), HSV-Net achieved a Dice score of 87.8%, also exceeding the 87.1% reported for nnU-Net v2. Secondary outcomes included a Boundary F1 score of 86.3% in the QIN dataset and 83.6% in the LIDC-IDRI dataset, with a recorded latency of 58 ms.

Limitations noted include the fact that LUNA16 was not used for contour external validation. The results suggest that HSV-Net provides higher Dice and Boundary F1 scores for pulmonary nodule segmentation compared to nnU-Net v2. However, as a technical validation of a segmentation algorithm, these results do not directly translate to clinical outcomes or patient management.

How this fits prior evidence

This technical report addresses a gap in the technical tools available for imaging analysis in lung cancer. While prior coverage has focused on clinical management, such as radiation dose impacts on cardiac health, exercise for depressive symptoms, and non-pharmacological fatigue management, this report focuses on the underlying diagnostic technology. It provides a technical comparison of segmentation algorithms to improve the accuracy of identifying pulmonary nodules.

Researchers tested a new computer system called HSV-Net to see how well it can identify and outline lung nodules on CT scans. These nodules are often checked to monitor lung cancer. The study compared HSV-Net to a common existing tool called nnU-Net v2.

In tests using two different sets of images, HSV-Net achieved higher scores for accuracy and boundary detection than the older system. Specifically, it showed a Dice score of 90.1% on one set and 87.8% on another. These scores measure how well the computer matches the actual shape of the tumor.

It is important to note that this was a technical test of a computer algorithm, not a clinical trial on patients. While the results show the software is more precise at mapping the area of a tumor, it does not change how doctors treat patients directly. It is a tool designed to help provide more accurate images for medical professionals to review.

What this means for you:
A new AI tool shows higher accuracy in mapping lung cancer nodules on scans than current standard software.

Common questions

How accurate is the new HSV-Net system?

The HSV-Net system showed higher accuracy scores than the current nnU-Net v2 system. In one test, it achieved a Dice score of 90.1%, while the other system scored 88.6%. In a second test, HSV-Net scored 87.8% compared to 87.1% for the other system.

Is this a new treatment for lung cancer?

No, this is not a medical treatment or a clinical trial. It is a technical validation of a computer algorithm. The goal is to improve how accurately computers can outline and measure lung nodules on CT scans to help doctors see the area more clearly.

What are the benefits of using this AI for lung scans?

The system showed higher scores for both accuracy and boundary detection. It also showed a processing speed of 58 ms. These improvements mean the software can more precisely map the shape of a tumor compared to the older system.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedOct 2026
View Original Abstract ↓
Accurate voxel-level segmentation of pulmonary nodules on chest CT is needed for diameter and volume measurement, growth tracking, and quantitative assessment in lung cancer screening. The task remains difficult: nodules vary in attenuation, size, and contact with vessels or pleura, and clinically relevant morphology often lies in a thin, ambiguous margin. Existing systems commonly trade contour fidelity for speed—large prompt-driven foundation models can be accurate but slow, whereas compact CNN or SSM decoders are efficient yet tend to smooth spiculated and ground-glass borders. We propose HSV-Net (Hybrid State-space–Vision Network), a dual-stream 3D network that is prompt-free after nodule localization: an SSM3D stream provides whole-patch context with linear-complexity state-space blocks, and an OrthoLoRA stream adapts frozen DINOv2 features on axial, coronal, and sagittal slices. A Hybrid Gated Mixer (HGM) fuses the two streams before FPN decoding, and Progressive Contour Learning (PCL) supervises overlap, signed-distance-field geometry, and uncertainty-weighted contour refinement. On a 10-patient QIN Lung CT/QIN-LungCT-Seg development subset (n = 12 tumors; nested patient-level 5-fold CV), HSV-Net obtained the highest mean Dice (90.1% ± 1.0%; 95% CI [88.9, 91.3]) and Boundary F1 (86.3% ± 1.3%) among the compared methods on 128 × 128 × 64 patches, with a latency of 58 ms. A standard full-volume nnU-Net v2 baseline reached 88.6% ± 1.0% Dice on the same QIN folds, still below HSV-Net. On an independent LIDC-IDRI benchmark with expert volumetric consensus masks (186 patients/294 nodules; patient-level 5-fold CV within LIDC, not QIN→LIDC transfer), HSV-Net achieved 87.8% ± 1.1% Dice and 83.6% ± 1.3% Boundary F1, outperforming full-volume nnU-Net (87.1% ± 1.0% Dice). LUNA16 was retained only as a proxy size/localization check with diameter-matched spherical references, not as contour external validation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.